Synchronous biopsy followed by radiofrequency ablation in lung tumors: A clinical analysis of a single center
10.7507/1007-4848.202103020
- VernacularTitle:活检同步消融一体化诊疗方案治疗肺肿瘤的单中心临床分析
- Author:
Qin LIU
1
;
Qingbing WANG
1
;
Yawen SUN
2
;
Xiaoxia GUO
1
;
Wei HUANG
1
;
Dingyi XIAO
1
;
Zhongmin WANG
1
;
Xiaoyi DING
1
;
Zhiyuan WU
1
Author Information
1. Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, P.R.China
2. Department of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, P.R.China
- Publication Type:Journal Article
- Keywords:
Lung tumors;
ablation;
biopsy;
intervention therapy
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(11):1305-1309
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the application value of synchronous CT-guided percutaneous biopsy followed by radiofrequency ablation in the diagnosis and treatment of lung tumors. Methods The clinical data of 21 patients with lung tumors were retrospectively analyzed. There were 8 males and 13 females aged 68 (51, 73) years. A total of 24 lesions underwent CT-guided percutaneous biopsy and concurrent radiofrequency ablation. The effectiveness and safety of this protocol were analyzed. Results All 21 patients successfully completed the procedures. The diameter of 24 lesions was 17.0 (13.3, 19.0) mm. Biopsy specimens met the requirements of pathological diagnosis, and the effectiveness of specimens was 100.0%. The incidence of small amount of pneumothorax/pleural shrinkage after procedures was 19.0% (4/21) and the incidence of tension pneumothorax was 4.7% (1/21). There was no obvious bleeding or other complications. Conclusion Synchronous CT-guided percutaneous biopsy followed by radiofrequency ablation combines two interventional techniques, which is safe and effective in the diagnosis and treatment of lung tumors, and it is worthy of popularization and application in clinic.
